• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺氧通过抑制羟化作用和改变脂筏的结构降低依利司他滨的效率。

Hypoxia reduces the efficiency of elisidepsin by inhibiting hydroxylation and altering the structure of lipid rafts.

机构信息

Department of Biophysics and Cell Biology, University of Debrecen, Nagyerdei krt. 98, Debrecen 4032, Hungary.

出版信息

Mar Drugs. 2013 Dec 2;11(12):4858-75. doi: 10.3390/md11124858.

DOI:10.3390/md11124858
PMID:24317474
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3877891/
Abstract

The mechanism of action of elisidepsin (PM02734, Irvalec®) is assumed to involve membrane permeabilization via attacking lipid rafts and hydroxylated lipids. Here we investigate the role of hypoxia in the mechanism of action of elisidepsin. Culturing under hypoxic conditions increased the half-maximal inhibitory concentration and decreased the drug's binding to almost all cell lines which was reversed by incubation of cells with 2-hydroxy palmitic acid. The expression of fatty acid 2-hydroxylase was strongly correlated with the efficiency of the drug and inversely correlated with the effect of hypoxia. Number and brightness analysis and fluorescence anisotropy experiments showed that hypoxia decreased the clustering of lipid rafts and altered the structure of the plasma membrane. Although the binding of elisidepsin to the membrane is non-cooperative, its membrane permeabilizing effect is characterized by a Hill coefficient of ~3.3. The latter finding is in agreement with elisidepsin-induced clusters of lipid raft-anchored GFP visualized by confocal microscopy. We propose that the concentration of elisidepsin needs to reach a critical level in the membrane above which elisidepsin induces the disruption of the cell membrane. Testing for tumor hypoxia or the density of hydroxylated lipids could be an interesting strategy to increase the efficiency of elisidepsin.

摘要

埃利色丁(PM02734,Irvalec®)的作用机制被认为涉及通过攻击脂筏和羟化脂质来实现膜通透性。在这里,我们研究了缺氧在埃利色丁作用机制中的作用。在缺氧条件下培养会增加半最大抑制浓度,并使药物几乎与所有细胞系的结合减少,而用 2-羟基棕榈酸孵育细胞可逆转这种情况。脂肪酸 2-羟化酶的表达与药物的效率强烈相关,与缺氧的影响呈负相关。数量和亮度分析以及荧光各向异性实验表明,缺氧会减少脂筏的聚集并改变质膜的结构。尽管埃利色丁与膜的结合是非协同的,但它的膜通透性效应的希尔系数约为 3.3。这一发现与共聚焦显微镜观察到的埃利色丁诱导的质膜锚定 GFP 脂筏簇相一致。我们提出,埃利色丁在膜中的浓度需要达到一个临界水平,超过该水平,埃利色丁就会诱导细胞膜破裂。检测肿瘤缺氧或羟化脂质的密度可能是提高埃利色丁效率的一种有趣策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0007/3877891/55b1a56b3ef0/marinedrugs-11-04858-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0007/3877891/07236fe5b78c/marinedrugs-11-04858-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0007/3877891/18c386226fd8/marinedrugs-11-04858-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0007/3877891/6fa76402894f/marinedrugs-11-04858-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0007/3877891/0f0a63b65098/marinedrugs-11-04858-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0007/3877891/55b1a56b3ef0/marinedrugs-11-04858-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0007/3877891/07236fe5b78c/marinedrugs-11-04858-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0007/3877891/18c386226fd8/marinedrugs-11-04858-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0007/3877891/6fa76402894f/marinedrugs-11-04858-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0007/3877891/0f0a63b65098/marinedrugs-11-04858-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0007/3877891/55b1a56b3ef0/marinedrugs-11-04858-g005.jpg

相似文献

1
Hypoxia reduces the efficiency of elisidepsin by inhibiting hydroxylation and altering the structure of lipid rafts.缺氧通过抑制羟化作用和改变脂筏的结构降低依利司他滨的效率。
Mar Drugs. 2013 Dec 2;11(12):4858-75. doi: 10.3390/md11124858.
2
ErbB protein modifications are secondary to severe cell membrane alterations induced by elisidepsin treatment.埃尔宾蛋白的改变是由于依立替康处理引起的严重细胞膜改变的继发事件。
Eur J Pharmacol. 2011 Sep 30;667(1-3):91-9. doi: 10.1016/j.ejphar.2011.05.064. Epub 2011 Jun 2.
3
Elisidepsin Interacts Directly with Glycosylceramides in the Plasma Membrane of Tumor Cells to Induce Necrotic Cell Death.埃利西地辛直接与肿瘤细胞质膜中的糖基神经酰胺相互作用,诱导坏死性细胞死亡。
PLoS One. 2015 Oct 16;10(10):e0140782. doi: 10.1371/journal.pone.0140782. eCollection 2015.
4
Levels of SCS7/FA2H-mediated fatty acid 2-hydroxylation determine the sensitivity of cells to antitumor PM02734.SCS7/FA2H介导的脂肪酸2-羟基化水平决定细胞对抗肿瘤药物PM02734的敏感性。
Cancer Res. 2008 Dec 1;68(23):9779-87. doi: 10.1158/0008-5472.CAN-08-1981.
5
Epithelial-mesenchymal transition markers and HER3 expression are predictors of elisidepsin treatment response in breast and pancreatic cancer cell lines.上皮-间充质转化标志物和 HER3 表达是elisidepsin 治疗乳腺癌和胰腺癌细胞系反应的预测因子。
PLoS One. 2013;8(1):e53645. doi: 10.1371/journal.pone.0053645. Epub 2013 Jan 8.
6
Predictive factors of sensitivity to elisidepsin, a novel Kahalalide F-derived marine compound.预测 Elisidepsin(一种新型 Kahalalide F 衍生海洋化合物)敏感性的因素。
Mar Drugs. 2013 Mar 20;11(3):944-59. doi: 10.3390/md11030944.
7
Phase I, dose-escalating study of elisidepsin (Irvalec(®)), a plasma membrane-disrupting marine antitumor agent, in combination with erlotinib in patients with advanced malignant solid tumors.一项关于elisidepsin(Irvalec®)(一种破坏细胞膜的海洋抗肿瘤药物)与厄洛替尼联合用于晚期恶性实体瘤患者的I期剂量递增研究。
Invest New Drugs. 2016 Feb;34(1):75-83. doi: 10.1007/s10637-015-0305-8. Epub 2015 Dec 2.
8
HIF-1 is induced via EGFR activation and mediates resistance to anoikis-like cell death under lipid rafts/caveolae-disrupting stress.缺氧诱导因子 1(HIF-1)通过表皮生长因子受体(EGFR)的激活而被诱导,并在脂筏/小窝破坏应激下介导类似失巢凋亡的细胞耐药性。
Carcinogenesis. 2009 Dec;30(12):1997-2004. doi: 10.1093/carcin/bgp233.
9
PM02734 (elisidepsin) induces caspase-independent cell death associated with features of autophagy, inhibition of the Akt/mTOR signaling pathway, and activation of death-associated protein kinase.PM02734(elisidepsin)诱导 caspase 非依赖性细胞死亡,其与自噬的特征相关,抑制 Akt/mTOR 信号通路,并激活死亡相关蛋白激酶。
Clin Cancer Res. 2011 Aug 15;17(16):5353-66. doi: 10.1158/1078-0432.CCR-10-1948. Epub 2011 Jun 20.
10
Lipid rafts: cell surface platforms for T cell signaling.脂筏:T细胞信号传导的细胞表面平台
Biol Res. 2002;35(2):127-31. doi: 10.4067/s0716-97602002000200003.

引用本文的文献

1
2-Hydroxylation is a chemical switch linking fatty acids to glucose-stimulated insulin secretion.2-羟基化是一种将脂肪酸与葡萄糖刺激的胰岛素分泌联系起来的化学开关。
J Biol Chem. 2024 Dec;300(12):107912. doi: 10.1016/j.jbc.2024.107912. Epub 2024 Oct 21.
2
Impact of sex and hypoxia on brain region-specific expression of membrane androgen receptor AR45 in rats.性别和低氧对大鼠大脑区域特定雄激素受体 AR45 表达的影响。
Front Endocrinol (Lausanne). 2024 Jul 18;15:1420144. doi: 10.3389/fendo.2024.1420144. eCollection 2024.
3
It Takes More than Two to Tango: Complex, Hierarchal, and Membrane-Modulated Interactions in the Regulation of Receptor Tyrosine Kinases.

本文引用的文献

1
Eicosanoids and docosanoids in plasma and aorta of healthy and atherosclerotic rabbits.健康兔和动脉粥样硬化兔血浆及主动脉中的类二十烷酸和类二十二烷酸
J Vasc Res. 2013;50(5):372-82. doi: 10.1159/000350865. Epub 2013 Aug 17.
2
The Effect of Lidocaine · HCl on the Fluidity of Native and Model Membrane Lipid Bilayers.盐酸利多卡因对天然和模型膜脂双层流动性的影响。
Korean J Physiol Pharmacol. 2012 Dec;16(6):413-22. doi: 10.4196/kjpp.2012.16.6.413. Epub 2012 Dec 10.
3
A phase I and pharmacokinetic study of elisidepsin (PM02734) in patients with advanced solid tumors.
一个巴掌拍不响:受体酪氨酸激酶调控中的复杂、层级化及膜调节相互作用
Cancers (Basel). 2022 Feb 14;14(4):944. doi: 10.3390/cancers14040944.
4
Expression of Lipid-Metabolism Genes Is Correlated With Immune Microenvironment and Predicts Prognosis in Osteosarcoma.脂质代谢基因的表达与骨肉瘤的免疫微环境相关并可预测其预后。
Front Cell Dev Biol. 2021 Apr 16;9:673827. doi: 10.3389/fcell.2021.673827. eCollection 2021.
5
Fatty acid 2-hydroxylation inhibits tumor growth and increases sensitivity to cisplatin in gastric cancer.脂肪酸 2-羟化酶抑制作用抑制胃癌的生长并增加顺铂敏感性。
EBioMedicine. 2019 Mar;41:256-267. doi: 10.1016/j.ebiom.2019.01.066. Epub 2019 Feb 7.
6
Marine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance.具有抗增殖活性的海洋软体动物衍生剂有望成为克服化疗耐药性的抗癌药物。
Med Res Rev. 2017 Jul;37(4):702-801. doi: 10.1002/med.21423. Epub 2016 Dec 7.
7
Marine Compounds and Cancer: Where Do We Stand?海洋化合物与癌症:我们目前的进展如何?
Mar Drugs. 2015 Sep;13(9):5657-65. doi: 10.3390/md13095657. Epub 2015 Sep 2.
8
Elisidepsin Interacts Directly with Glycosylceramides in the Plasma Membrane of Tumor Cells to Induce Necrotic Cell Death.埃利西地辛直接与肿瘤细胞质膜中的糖基神经酰胺相互作用,诱导坏死性细胞死亡。
PLoS One. 2015 Oct 16;10(10):e0140782. doi: 10.1371/journal.pone.0140782. eCollection 2015.
一项在晚期实体瘤患者中进行的elisidepsin(PM02734)的 I 期和药代动力学研究。
Cancer Chemother Pharmacol. 2012 Nov;70(5):673-81. doi: 10.1007/s00280-012-1951-6. Epub 2012 Aug 25.
4
Complete and sustained objective response per RECIST to Irvalec (PM02734) in undifferentiated large cell esophageal adenocarcinoma: A case report and a review of the literature.根据RECIST标准,未分化大细胞食管腺癌对Irvalec(PM02734)产生完全且持续的客观反应:一例病例报告及文献综述
Case Rep Oncol. 2012 May;5(2):354-8. doi: 10.1159/000341104. Epub 2012 Jul 5.
5
Stereospecificity of fatty acid 2-hydroxylase and differential functions of 2-hydroxy fatty acid enantiomers.脂肪酸 2-羟化酶的立体专一性和 2-羟脂肪酸对映异构体的差异功能。
J Lipid Res. 2012 Jul;53(7):1327-35. doi: 10.1194/jlr.M025742. Epub 2012 Apr 19.
6
ErbB3 expression predicts sensitivity to elisidepsin treatment: in vitro synergism with cisplatin, paclitaxel and gemcitabine in lung, breast and colon cancer cell lines.ErbB3 表达预测对 Elisidepsin 治疗的敏感性:在肺、乳腺和结肠癌细胞系中与顺铂、紫杉醇和吉西他滨的体外协同作用。
Int J Oncol. 2012 Jul;41(1):317-24. doi: 10.3892/ijo.2012.1425. Epub 2012 Apr 3.
7
PM02734 (elisidepsin) induces caspase-independent cell death associated with features of autophagy, inhibition of the Akt/mTOR signaling pathway, and activation of death-associated protein kinase.PM02734(elisidepsin)诱导 caspase 非依赖性细胞死亡,其与自噬的特征相关,抑制 Akt/mTOR 信号通路,并激活死亡相关蛋白激酶。
Clin Cancer Res. 2011 Aug 15;17(16):5353-66. doi: 10.1158/1078-0432.CCR-10-1948. Epub 2011 Jun 20.
8
ErbB protein modifications are secondary to severe cell membrane alterations induced by elisidepsin treatment.埃尔宾蛋白的改变是由于依立替康处理引起的严重细胞膜改变的继发事件。
Eur J Pharmacol. 2011 Sep 30;667(1-3):91-9. doi: 10.1016/j.ejphar.2011.05.064. Epub 2011 Jun 2.
9
Irvalec inserts into the plasma membrane causing rapid loss of integrity and necrotic cell death in tumor cells.Irvalec 插入质膜,导致肿瘤细胞迅速丧失完整性并发生坏死性细胞死亡。
PLoS One. 2011 Apr 27;6(4):e19042. doi: 10.1371/journal.pone.0019042.
10
Fatty acid 2-hydroxylase mediates diffusional mobility of Raft-associated lipids, GLUT4 level, and lipogenesis in 3T3-L1 adipocytes.脂肪酸 2-羟化酶调节脂筏相关脂质、GLUT4 水平和 3T3-L1 脂肪细胞的脂生成的扩散迁移性。
J Biol Chem. 2010 Aug 13;285(33):25438-47. doi: 10.1074/jbc.M110.119933. Epub 2010 Jun 2.